Back to results
US 2014/0370083 A1Published application
5-aminosalicylic acid capsule formulation
AssigneeWarner Chilcott Company, LLC
InventorsEmma Boyd, Deborah Leigh Caldwell, Catherine Coulter, Ryan Loughlin, Stephen McCullagh
Life of this patent
Estimating the term…
Abstract
A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed.
Claims30
A dosage form comprising:
- (a) a capsule shell;
- and
- (b) at least one tablet within the capsule shell, the at least one tablet containing 5-aminosalicylic acid or a salt thereof as an active ingredient and having an enteric coat.
A dosage form comprising:
- (a) a capsule shell;
- and
- (b) at least one tablet within the capsule shell, the at least one tablet containing 5-aminosalicylic acid or a salt thereof as an active ingredient and having an enteric coat,
- wherein the capsule shell has less than about 10% by weight moisture content at a relative humidity of 60% and a temperature of 25° C.
1 more element
A method of improving the handling properties of a 5-aminosalicylic acid dosage form comprising the steps of:
- providing at least one tablet containing 5-aminosalicylic acid or a salt thereof as an active ingredient and having an enteric coat;
- and
- encapsulating the at least one tablet in a capsule shell.
A method of improving the stability of a 5-aminosalicylic acid dosage form comprising the steps of:
- providing at least one tablet containing 5-aminosalicylic acid or a salt thereof as an active ingredient and having an enteric coat;
- and
- encapsulating the at least one tablet in a capsule shell,
- wherein the capsule shell has less than about 10% by weight moisture content at a relative humidity of 60% and a temperature of 25° C.
1 more element
Dependencies are inferred from the claim text.